Диссертация (1141076), страница 13
Текст из файла (страница 13)
– С. 68–71.47.Харченко, В.П. Значение ангиографии в диагностике рака почки / В.П.Харченко, А.Д. Каприн, А.П. Ананьев // Вестник рентгенологии ирадиологии. – 2001. – №1. – С. 50–54.48.Харченко, В.П. Результаты пункционных диагностических и лечебныхвмешательств на органах забрюшинного пространства и малого таза подконтролем ультразвукового сканирования / В.П. Харченко, А.Д. Каприн,Р.А.
Гафанов [и др] // Урология. – 2000. – № 5. – С. 51–52.49.Черданцева, Т.М. Патоморфологический и молекулярно-биологическийанализ почечно-клеточного рака. Диагностика и прогноз: автореф. дис....д.м.н.: 14.03.02 / Черданцева Т.М. – Барнаул, 2014. – 39–59 с.50. ШлоповВ.Г.,морфология,Лодавскийгистохимия,Е.А.Светлоклеточные опухолиультраструктура,почек:дифференциальнаядиагностика // Архив патологии. – 1989. - №3.-С. 44-4851.Юрин,А.Г.Неметастатическийсветлоклеточныйракпочек:прогностическая значимость морфометрических и биомолекулярных91факторов (БМФ) / А.Г. Юрин // Вопросы онкологии.
– 2009. – №2. –С.177–182.52.Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCCand CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol.2000;24: Р. 203–210.53.Baek S.-J. Baseline correction using asymmetrically reweighted penalized leastsquares smoothing / S.-J. Baek, A.
Park, Y.-J. Ahn, J. Choo // The Analyst. –2015. – 140(1): P. 250–257.54.Bellayr I.H., Mu X., Li Y. Biochemical insights into the role of matrixmetalloproteinases in regeneration: challenges and recent developments // NIHPublic Access Author Manuscript.
2010. P.1762.55. Bromwich E. The relationship between T-lymphocyte infiltration, stage,tumour grade and survival in patients undergoing curative surgery for renal cellcancer // Br. J. Cancer/ - 2003 (17) – 89(10). P.1906-1908.56.Bonsib S.M. Renal neoplasms: an update on immunohistochemical andhistochemical features / S.M. Bonsib, A. Bhalodia // Connection.
– 2010. –26:P. 178–86.57.Catherin R. Imaging in renal cell cancer / R. Catherin, B. Xavier, Sofiane elGhali // EUA Update Series Vol.1. – 2003. – P. 209–214.58.Chen Q. Growth-induced stress enhances epithelial-mesenchymal transitioninduced by IL-6 in clear cell renal cell carcinoma via the Akt/GSK-3β/β-cateninsignaling pathway / Chen. Q, Yang D Zong, H, Zhu L, Wang L, Wang X, ZhuX, Song X., Wang J //Oncogenesis. – 2017. – 6: e375.59.Cheville J.C. Comparison of outcome and prognostic features among histologicsubtytes renal cell carcinoma / J.C. Cheville, C.M.
Lohse, et al. // Am JSurgpathol. – 2003. – 27(5): P.612–624.60.Chow WH. Epidemiology and risk factors for kidney cancer / WH. Chow, LDDong, SS Devesa // Nat Rev Urol. – 2010. –7(5): P.245–57.61. Couapel JP, Senhadji L, Rioux-Leclercq N, Verhoest G, Lavastre O, deCrevoisier R, Bensalah K. Optical spectroscopy techniques can accurately92distinguish benign and malignant renal tumours. BJU Int. 2013;111:P. 865–871.62.Crow P. Assessment of fiberoptic near-infrared raman spectroscopy fordiagnosis of bladder and prostate cancer / P. Crow, A.
Molckovsky, N. Stone,Uff J, B. Wilson, WongKeeSong LM // Urology. – 2005. – 65(6): P. 1126–30.63.Crow P. The Use of Raman Spectroscopy to Identify and Grade ProstaticAdenocarcinoma In Vitro / P. Crow, N. Stone, C.A. Kendall C.A. et al. / BritishJournal of Cancer. – 2003. – 89: P. 106–108.64.Dabbs D.J. Diagnostic immunohistochemistry.– 3rd ed. – Edinburgh: ChurchillLivingstone, 2010.
P. 673.65.Delahunt B. Papillary renal cell carcinoma: a clinicopathologic andimmunohistochemical study of 105 tumors / B. Delahunt, J. N. Eble // ModPathol. – 1997. – 10: P. 537–44.66.Draga R.O. In Vivo Bladder Cancer Diagnosis by High-volume RamanSpectroscopy / R.O. Draga, M.C. Grimbergen, L.P. Vijverberg P.L. et al. //Anal.
Chem. – 2010. – 82: P. 5993–5999.67.Duraipandian S. Near-infrared-excited confocal Raman spectroscopy advancesin vivo diagnosis of cervical precancer / S. Duraipandian, W. Zheng, Ng J. et al// J Biomed Opt. – 2013. – Jun;18(6): 067007.68.Emaetig F. Survivin expression renal cell carcinoma and its correlation withclinicopathological parameters / F.
Emaetig, K. E. Gehani, I. E. Hasadi et al. //J. Interdiscipl. Histopathol. – 2013. – Vol. 1. – №4. – P. 184–194.69.Evers DJ. Optical spectroscopy: current advances and future applications incancer diagnostics and therapy / DJ Evers, BHW Hendriks, GW Lucassen, TJNRuers // Future Oncol.
– 2012. – 8(3): P. 307–309.70.Ferrara N. The biology of VEGF and its receptors / N. Ferrara, H. P. Gerber, J.LeCouter // Nat. Med. – 2003. – Vol. 9. – №6. – Р. 669–676.71.Fuhrman S.A. Prognostic significance of morphologic parameters in renal cellcarcinoma / S.A. Fuhrman, L.C. Lasky, C.
Limas // Am J SurgPathol. – 1982. –6: P. 655–63.9372.Gayed B.A. Ki67 is an independent predictor of oncological outcomes inpatients with localized clear-cell renal cell carcinoma / B.A. Gayed, R. F.Youssef, A. Bagrodia et al. // BJU Int. – 2014. – Vol. 113. – № 4. – P. 668–673.73.Huang E. Y. Discremination of renal cell carcinoma from normal renalparenchyma using Raman spectroscopy // Huang E.Y., Liao, Ying-Hsiang, Lin,Alex T.L.
// Journal of Urology. – 2012. – 187.4: 398.74.Huang E. Y. Raman spectral analysis of renal tissue: a novel application / E. Y.Huang, Shou-Chia Chu, He Guei Chen // J. Raman Spectrosc. – 2014. – 45(9):788–793.75.Huang Z. In vivo early diagnosis of gastric dysplasia using narrow-band imageguided Raman endoscopy / Huang Z, Bergholt MS, Zheng W et al.
// J BiomedOpt. – 2010. – May–Jun;15(3): P. 037017.76.Kendall C. Evaluation of Raman probe for oesophageal cancer diagnostics / C.Kendall, J. Day, J. Hutchings et al. // Analyst. – 2010. – Dec;135(12): P. 303841.77.Kendall C. Raman spectroscopy, a potential tool for the objective identificationand classification of neoplasia in Barrett's oesophagus / C. Kendall, N. Stone,N. Shepherd N et al.
// J Pathol. – 2003. – Aug;200(5): P. 602-9.78.Kharaishvili G. The role of cancer-associated fibroblasts, solid stress and othermicroenvironmental factors in tumor progression and therapy resistance / G.Kharaishvili, D. Simkova, K. Bouchalova et al. // Cancer Cell International. –2014. – 14(41): 1–8.79.Klatte T. Hypoxia-inducible factor 1-alpha in clear cell renal cell carcinoma / T.Klatte, D. B. Seligson, S. B. Riggs et al. // Clin. Cancer Res Vol.13. – 2007.
–P. 7388–7393.80.Kowalczyk D1, Skorupski W, Kwias Z, Nowak J. Flow cytometric analysis oftumour-infiltrating lymphocytes in patients with renal cell carcinoma. Br J Urol.1997 Oct;80(4): P. 543-7.9481.Kuroda N. Review of renal oncocytoma with focus on clinical andpathobiological aspects / N. Kuroda, M. Toi, M.Hiroi et al. // Histol.Histopathol. – 2003. – 18: P. 935–42.82.Lam J.S. Renal cell carcinoma 2005: new frontiers in staging, prognosticationand targeted molecular therapy / J.S. Lam, O. Shvarts, J. T. Leppert et al. // JUrol.
– 2005. – 173: P. 1853–62.83.Leroy X, Moukassa D, Copin MC, Saint F, Mazeman E, Gosselin B. Utilityof cytokeratin 7 for distinguishing chromophobe renal cell carcinoma fromrenal oncocytoma. Eur Urol. 2000;37: P. 484–487.84.Liu L. Immunohistochemical Analysis of Chromophobe Renal Cell Carcinoma,Renal Oncocytoma, and Clear Cell Carcinoma. An Optimal and Practical Panelfor Differential Diagnosis / L.
Liu, J. Qian, H. Singh et al. // Arch Pathol LabMed Vol 131. – August 2007. – P. 1290–96.85.Ljungberg B. Tumor vascular endothelial growth factor (VEGF) mRNA inrelation to serum VEGF protein levels and tumor progression in human renalcell carcinoma / B. Ljungberg, J. Jacobsen, S.
Haggstrom‐Rudolfsson et al. //Urol.Res Vol.31. – 2003. – P. 335–340.86.Ljungberg B. Почечно-клеточныйрак / B. Ljungberg, N. Cowan, D.C.Hanbury, M. Hora, M.A. Kuczyk, A.S. Merseburger, P.F.A. Mulders, J-J.Patard, I.C. Sinescu; Перевод: Ю.С. Серомолот/ Научное редактирование:В.Б.
Матвеев // Европейская ассоциация урологов, – 2010. C. 25-50.87.Luan D. Truong. Immunohistochemical Diagnosis of Renal Neoplasms / LuanD. Truong, Steven S. Shen // Arch Pathol Lab Med Vol 135. – Jan 2011. – P.92–107.88.Martignoni G., Brunelli M., Gobbo S. et al. Role of molecular markers indiagnosis and prognosis of renal cell carcinoma // Anal Quant Cytol Histol2007; 29: P.41-9.89.Mc Cleannan B.L.
The imaging evalution of renal cell carcinoma, diagnosis andstaging / B.L. Ma Cleannan, L.A. Deyoe // Radiol. Clin. North Am Vol.32. –1994. – P.55–69.9590.Mert S. Kidney tumor staging using surface-enhanced Raman scattering / S.Mert, E. Ozbek, A. Otunctemur, M.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
